LOH (loss of heterozygoty)
. A similar profile is observed for the second microsatellite marker D17S1879 (right panel). For the two markers, there is also a decrease in the allelic peak ratio from the normal tissue of the patient to the primary RCC and the corresponding metastasis.
Supplementary Figure 2
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